Transmembrane sodium-ion gradients provide energy that can be harnessed by 'secondary transporters' to drive the translocation of solute molecules into a cell. Decades of study have shown that such sodiumcoupled transporters are involved in many physiological processes, making them targets for the treatment of numerous diseases. Within the past year, crystal structures of several sodium-coupled transporters from different families have been reported, showing a remarkable structural conservation between functionally unrelated transporters. These atomic-resolution structures are revealing the mechanism of the sodiumcoupled transport of solutes across cellular membranes.
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. A large class of these proteins, termed secondary transporters, use the discharge of an ionic gradient to power the 'uphill' translocation of solute molecules across membranes. By coupling solute movement to ion transport, secondary transporters are able to concentrate solutes across a membrane by a factor of 10 6 (ref. 2) , and solute flux can occur 10 5 times faster than by simple passive diffusion 3, 4 . Secondary transporters are found in all species throughout the kingdoms of life 5 . In humans, they participate in a range of physiological processes, from the uptake of nutrients in the intestine 6 to the transport of Na + and Cl -in the kidney 7 and the removal of neurotransmitters from the synaptic cleft 8 . Secondary transporters are therefore the target of multiple therapeutic agents, including thiazide diuretics, which inhibit a Na + /Cl -symporter in the distal convoluted tubule of the kidney 9 , and selective serotonin re-uptake inhibitors (antidepressants), which block the activity of the serotonin transporter 10 . At the level of primary structure, analyses of amino-acid sequence suggest that there are more than 100 distinct families of secondary transporter 11 , with more than 40 families identified in humans alone 12 .
With respect to biological function, these amino-acid sequences encode transporters that act on a range of substrates including elemental cations and anions, aromatic neurotransmitters, nutrients and di-and tripeptides 13, 14 . Transport is usually driven by proton or sodium transmembrane gradients 12, 13 . In this Review, we focus on transporters that are coupled to sodium ions. We will discuss what recent crystallographic advances relating to sodium-coupled transporters can tell us about the coupling of substrates to ions, the conformational state of the transporter at different stages of the transport cycle, the mechanisms of transport inhibition, and how the substrate and ion pathway is alternately opened and closed -or gatedto maintain a tightly coupled transport mechanism.
Alternating-access mechanism
The mechanism by which secondary transporters couple the chemical potential of an ionic gradient to the translocation of solute has been debated for decades. Peter Mitchell provided early insights into the mechanism of secondary transporters by suggesting that they occupy two alternating structural states: one in which the substrate-binding pocket is accessible to extracellular solution ('open-to-out'), and another in which the binding pocket is accessible to the cytoplasm ('open-to-in') 15 . In this simple model, coupled transport occurs by the synergistic binding of substrate and ion to the open-to-out state followed by isomerization of the transporter to the open-to-in state, allowing the release of both substrate and ion to the cytoplasm 16 . In the late 1950s and 1960s, the basic idea of a two-state alternating-access mechanism was recast in several forms, from the 'gate-type non-carrier' mechanism of Clifford Patlak 17 to the two-state 'allosteric model' of George Vidaver 18 and the 'alternating access' model of Oleg Jardetzky 19 . Molecular mechanisms of secondary transporters based on atomic structures did not emerge until almost 40 years later, largely because these transporters are hydrophobic and dynamic, making them difficult to crystallize. In 2002, the first crystal structure of a secondary transporter was reported 20 , the proton-driven multidrug efflux pump AcrB of the resistance nodulation cell division (RND) family from Escherichia coli. In 2003, the crystal structures of two major facilitator superfamily (MFS) transporters were solved: the glycerol-3-phosphate/phosphate antiporter GlpT 21 and the proton-coupled lactose symporter LacY
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. Even though AcrB has a markedly different fold from the MFS transporters, each of these structures revealed an internal two-fold structural pseudosymmetry that relates the amino-terminal half of the transporter to the carboxy-terminal half by an axis running through the centre of the transporter, approximately perpendicular to the membrane. Furthermore, the outward-facing conformations adopted by GlpT and LacY suggest that the transport mechanism involves a 'rocker switch' motion of the two symmetry-related halves, alternately opening and closing 'gates' to the extracellular and intracellular solutions.
The first atomic-resolution structural insights into the mechanisms of sodium-coupled secondary transporters were reported in 2004 and 2005 with the structures of the aspartate transporter GltPh 23 of the dicarboxylate/amino-acid:cation symporter (DAACS) family, followed by the Na + /H + antiporter NhaA from E. coli 24 and the bacterial leucine transporter LeuT 25 of the neurotransmitter:sodium symporter (NSS) family. The structures of GltPh, NhaA and LeuT not only revealed unique membrane protein folds but also reinforced the theme of internal two-fold Unlocking the molecular secrets of sodium-coupled transporters HP2   TM1   TM2   TM6   TM1   TM3   HP1   TM7   TM8 C   N   H  P  2  a  H  P  2  b  S  TM3  TM5  TM6   TM7a   TM8   TM7b   TM4   TM5  TM5   TM6   TM3   TM5   TM8   TM2   TM2  TM1   TM5   TM7 structural symmetry and discontinuous transmembrane helices 26 . GltPh, which assembles as a homotrimer, displays a pseudo-two-fold symmetrical relationship between crucial elements of the protomer architecture, including two re-entrant hairpin loops (HP1 and HP2), together with the transmembrane helix TM7a and the first half of TM8 (ref. 23) . The relevance of the two-fold axis to the transporter mechanism is particularly striking, and it suggests that HP1 and HP2 may undergo alternating, symmetry-related motions that open and close access to the substrate-and ion-binding sites 23 ( Fig. 1) . In LeuT, which has a different fold from GltPh, an internal two-fold pseudo-symmetry axis, running parallel to the membrane plane through the centre of the transporter, relates the first five transmembrane helices (TM1-TM5) to the second five helices (TM6-TM10) 25 ( Fig. 2) . Surprisingly, the fold seen in LeuT was also observed in the subsequently reported structure of the galactose transporter vSGLT of the solute:sodium symporter (SSS) family 27 , and in the benzyl-hydantoin transporter Mhp1 of the nucleobase:cation symporter (NCS1) family 28 . Both vSGLT (ref. 27 ) and Mhp1 (ref. 28) contain the '5+5' inverted structural symmetry motif defined by TM1-TM10 of LeuT, even though these three transporters do not share significant aminoacid sequence identity or have the same number of transmembrane segments. In vSGLT, which has 14 transmembrane helices compared with 12 in LeuT and Mhp1, an N-terminal transmembrane helix precedes the 5+5 helix repeat and three additional helices follow the repeat. That different transporters have the same common helix core but have additional transmembrane segments on the periphery supports the idea that the two-fold-related 5+5 transmembrane repeat defines the fundamental machinery of these transporters.
Not only have the crystal structures of vSGLT, LeuT and Mhp1 effectively 'collapsed' the SSS 29 , NSS 30 and NCS1 transporter families into one structural group, they also suggest that other secondary transporters, previously believed to belong to distinct families, may also have LeuT-like folds. The similarity in architecture among LeuT, vSGLT and Mhp1 further implies commonalities in mechanism, ranging from the principles of substrate and ion binding and specificity to conformational changes associated with transport. Atomic models of these functionally disparate yet structurally related transporter families have provided insight into the principles of sodium-coupled transport, and are beginning to clarify an alternating-access mechanism that is distinctly different from that of the MFS family. Conversely, comparison of the structurally disparate LeuT and GltPh transporters suggest commonalities in the concept of 'gates' , how they function in the alternating-access mechanism, and in the mechanism of competitive inhibition.
A central pathway inside a scaffold
Close inspection of the LeuT, vSGLT and Mhp1 structures (Fig. 2) shows that the 5+5 transmembrane motif consists of two interior pairs of symmetry-related helices -TM1 and TM6, and TM3 and TM8 -that are nested within an outer ring of helices, TM2, TM4, TM5, TM7, TM9 and TM10 (numbered according to LeuT). Consistent with mutagenesis and functional studies [31] [32] [33] [34] , these interior pairs largely define the central translocation pathway that contains the binding sites for substrate and ions. The three structures show that the substrate-binding site lies in the centre of the interior pairs, and coincides with the internal two-fold symmetry axis.
Among the outer ring of helices, symmetry-related TM4 and TM5, and TM9 and TM10, form inverted V-shaped pincers that cradle the interior pair of TM3 and TM8, whereas TM2 and TM7, also related by the two-fold axis of symmetry, link TM1 and TM6 with the intracellular and extracellular helix-loop-helix structures, IL1 and EL4. We suggest that the outer ring of helices, which nestles around the interior pairs, provides a framework to stabilize the transporter within the lipid membrane, and that it couples conformational changes on one side of the membrane to movements on the other side.
The central translocation pathway surrounded by a protein scaffold is also observed in the GltPh fold (Fig. 1) . In GltPh, the transport machinery of HP1, HP2, TM7 and TM8, forming a C-terminal domain, is enveloped by a ring of six transmembrane helices from the N-terminal domain of the transporter. In this case, the crucial role of the C-terminal domain in defining the transport pathway was suggested by studies showing that functionally important residues were localized to the C terminus, and that the C-terminal domain was more highly con- TM6b   TM8  TM3   TM2   TM11   TM12  TM10   EL4   TM2   TM4   TM8   TM4   TM8   TM9   TM1  TM7   TM6   TM9   TM10   TM3   TM5   TM9   TM5   Out   In   TM1  TM1  TM10   TM8  TM8  TM6  TM6   TM3   R30 TM1   TM7   TM6   S355   T354   A351   G20  G20   V23   S355   T354   A351  V23   TM8  TM1  TM8  TM1   TM10   TM3 Gal
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served than the N-terminal one [35] [36] [37] . For GltPh and its orthologues, the scaffold of TM1-TM6 not only supports elements of the transport pathway, but also mediates essential intersubunit contacts in the trimer.
Substrate-and ion-binding sites
LeuT has a single substrate-binding site at its centre, surrounded by the interior helices, TM1, TM3, TM6 and TM8 (ref. 25) . The binding sites for galactose in vSGLT 27 and benzyl-hydantoin in Mhp1 28 are also similarly located (Fig. 3a) . Directly adjacent to the primary binding site, TM1 and TM6 in LeuT and Mhp1, or TM2 and TM7 in vSGLT, have interruptions in their helical conformations, a structural feature seen in other membrane proteins that transport ions 24, 38, 39 . The interruption in the α-helical structures in the proximity of the binding site exposes main-chain hydrogen-bonding partners and orients the helical dipoles to create a polar environment for coordinating substrate and ions within the lipid bilayer 25 . These electrostatic elements, together with side-chain atoms, sculpt the steric, chemical and electrical properties of the binding pocket, conferring on a given transporter selectivity for a substrate based on its size, polarity and charge 40 . Recent ligand-binding experiments and steered-molecular-dynamics simulations of LeuT have suggested that there is an additional secondary binding site between the primary site and the bulk extracellular solution, located near R30 and D404 (refs 41, 42) . It has been proposed 41 that the simultaneous occupancy of this secondary site triggers the (Fig. 3b) . We suggest that this site is transiently occupied as substrates move from the extracellular vestibule to the primary binding site when the transporter is in the open-to-out conformation.
The high-resolution structure of LeuT also identified the presence of two Na + binding sites, which we label as Na1 and Na2 (ref. 25) . The sodium ion at the Na1 site is octahedrally coordinated by five protein ligands and the carboxylate of the substrate leucine (Fig. 3c) , demonstrating that ion and substrate binding are directly coupled. By contrast, the Na2 site is located roughly 6 Å away from the substrate in LeuT and the sodium ion at this site is bound with a trigonal bipyramidal coordination geometry (Fig. 3d) . Intriguingly, by structural comparison, a sodium-ion binding site similar to the Na2 site in LeuT has been identified in both vSGLT and Mhp1, positioned about 10 Å away from the substrates 27, 28 . Although the resolutions of the vSGLT and Mhp1 structures are not high enough to unambiguously assign a sodium ion to the site, a sodium ion at this position in vSGLT is supported by biochemical and mutagenesis studies on vSGLT and other SSS family members, including the sodium/iodide symporter 27, 43, 44 . These observations indicate a role for an ion bound at the Na2 site not only in substrate binding, but also in conformational changes associated with substrate transport. Studies on GAT1 (ref. 45), as well as molecular-dynamic and free-energy simulations of LeuT 46 , suggest that the Na2 site is a low-affinity site that can readily give up its ion to the bulk phase, promoting release of the substrate 47 . Sodium-to-substrate stoichiometry varies not only between sodiumcoupled transporters, but also between members of the same family, depending on the thermodynamic driving force required for substrate uptake 4 . The requirement for transport varies from one to three sodium ions per substrate in the NSS 2,48-50 and SSS families 44,51-53 (Table 1) . Because vSGLT and Mhp1 probably have a sodium-ion binding site similar to the LeuT Na2 site, we suggest that this is a common ion site for divergent transporters and is essential for coupled substrate binding and symport. Although the Na1 site is less conserved among these transporters from different families, a sodium ion bound at this site not only enhances substrate binding for members of the NSS family, but also provides favourable interactions with the co-transported chloride ion 54, 55 . Some LeuT orthologues couple substrate transport to three sodium ions, but there is no direct experimental evidence for the location of a third sodium-ion binding site 4 .
Conformational states
The crystal structures of LeuT 25, 40, 56 , Mhp1 (ref. 28) , vSGLT 27 and GltPh 23, 57 provide evidence for the conformations of sodium-coupled secondary transporters as they proceed through the transport cycle. These structures are consistent with a mechanism of transport ( 14 are grouped into the three known structural folds. Where applicable, the SLC class 12 is indicated in parenthesis. The name of each fold is based on the first transporter structure solved that has that fold. Representative transporters from each family are listed, and ion stoichiometry is indicated in the 'Co-transported ions' column when supported by biochemical data (www.tcdb.org) 14 . Transporters for which crystal structures have been determined are italicized. Some of the transporters are H + rather than Na + dependent.
LeuT-Trp bound substrate) , through a potassium-bound state (as is the case for glutamate 58 and serotonin transporters 59 ), or back through a T M S state (with substrate exchange). One observation from the crystallographic studies is the presence of a stable occluded state for the substrate-and ion-bound ternary complex of each of the four transporters (Fig. 4a) . This state is characterized by the bound substrate residing in a closed or partly occluded binding pocket, where dissociation from the pocket would require a conformational change. Despite the common steric occlusion of the substrate, the degree to which the four transporters block solvent accessibility to the binding pocket from the extracellular and cytoplasmic sides varies (Fig. 4a) .
In the substrate-bound state of Mhp1 and LeuT, the occluded state has an outward-facing conformation (T M S out ), with the extracellular pathway being kept open to solvent. In LeuT, the extracellular solventexposed region is formed by a large hydrophobic vestibule. At the base of this vestibule are two highly conserved residues, Tyr 108 and Phe 253, which close the top of the binding pocket, creating an occluded substrate-binding site. In Mhp1, the structural elements that occlude the substrate benzyl-hydantoin are different from those of LeuT and involve the N-terminal half of TM10. GltPh also has an outward-facing occluded conformation (Fig. 4a) . Aspartate is bound between the tips of the HP1 and HP2 loops, which are closed over the binding site like lids, preventing the dissociation of substrate to either side of the transporter.
In contrast to LeuT and Mhp1, the occluded state of vSGLT adopts an inward-facing conformation (T M S in ), exposing a cavity to intracellular solution (Fig. 4a) , consistent with accessibility studies carried out on PutP 43 and SERT [60] [61] [62] [63] , orthologues of vSGLT and LeuT, respectively. Akin to leucine binding in LeuT, galactose is bound to vSGLT in a central binding pocket located above the intracellular vestibule, and is occluded from the vestibule by a conserved aromatic residue, Tyr 263. The inward-facing, occluded conformation of galactose-bound vSGLT is structurally different from that observed for substrate-bound LeuT or Mhp1, but there is a simple relationship between the two distinct states: the outward-and inward-facing states are related by the common two-fold axis of internal symmetry that relates the 5+5 transmembrane repeats, suggesting that the symmetrical relationship between LeuT and vSGLT approximates the mechanistic relationship between the T M S in and T M S out states. The crystal structure of Mhp1 in the unliganded form shows an opento-out conformation representing the T out state of the transport cycle (Fig. 4a) . Comparison of the ligand-bound occluded form of Mhp1 with the apo open-to-out state shows that the N-terminal half of TM10 bends inwards in response to ligand binding to form the occluded state. Further insight into the conformation of the T out state comes from the crystal structures of LeuT and GltPh bound to competitive inhibitors that trap the open-to-out conformations of the transporters 40, 57 (Fig. 4b) .
Mechanisms of inhibition
The crystal structures of LeuT bound to competitive and non-competitive inhibitors have afforded us a glimpse into the mechanisms of inhibition for the NSS family of transporters. In 2007, crystal structures of LeuT bound to the tricyclic antidepressants (TCAs) clomipramine, desipramine and imipramine were reported 56, 64 . These molecules have therapeutic value as competitive inhibitors of the human serotonin transporter 65 and block re-uptake of serotonin from synapses, thereby prolonging activation of the serotonin receptor. For LeuT, however, the mechanism of inhibition by TCAs is non-competitive 56 . The structures of the LeuT-TCA complexes reveal that the TCA molecule binds in the outward-facing vestibule, a partly hydrophobic cavity that binds other non-polar molecules, including n-octyl-β-D-glucopyranoside 40 . The TCA is situated directly above the R30-D404 salt bridge, where the guanidinium head group of the arginine has flipped to form a salt bridge with the aspartate, stabilizing the occluded state of LeuT (T M SI; Fig. 4b) , and preventing the further conformational changes needed for progress around the transport cycle. The identification of this inhibitory allosteric site is consistent with a general mechanism of non-competitive inhibition in which the substrate-binding site and inhibitor site do not overlap, trapping the transporter in an inactive state. The non-competitive mechanism for the inhibition of LeuT by TCAs is different from the competitive mechanism for the inhibition of SERT by TCAs 65 . Nevertheless, the structural principles revealed by the LeuT-TCA complexes define a mechanism of allosteric inhibition in NSS family transporters and, by extension, in other transporters with the LeuT fold.
The structural basis for competitive inhibition was recently revealed by the crystal structure of LeuT bound to tryptophan 40 . Tryptophan acts as a strut, where the bulky indole ring is wedged into the binding pocket, displacing the α-amino and α-carboxylate moieties outwards by about 2 Å relative to their positions in the leucine-bound occluded state. There is insufficient space to fully accommodate the indole ring in the substrate-binding pocket, so the transporter is effectively propped open by interactions of the inhibitor's α-substituents with TM1b and TM6a, and of the indole ring with TM3, TM8 and TM10. In this way, the transporter is locked open (T out I; Fig. 4b ) and blocked from progressing to the occluded T M S out state of the transport cycle. The crystal structure of GltPh bound to the competitive inhibitor TBOA, a bulky aspartate analogue, reveals a similar principle of competitive inhibition for transporters with the GltPh fold 57 (Fig. 4b) . The aspartate group of TBOA binds in a similar position as the substrate L-aspartate, lodged between TM7, TM8 and HP1. However, the large benzyl moiety of TBOA sticks out towards HP2, propping HP2 in an open conformation (Fig. 4b) , disrupting sodium site 2 and precluding the formation of the occluded state.
The observation that bulky substrate analogues act as competitive inhibitors of transport to stabilize an opening of the extracellular side of the transporter is supported by substituted cysteine accessibility method (SCAM) assays for the eukaryotic NSS homologue GAT1, as well as the human glucose transporter hSGLT, a member of the SSS family 66 . The consistency of these results with the LeuT-Trp crystal structure suggests that the mechanism of inhibition is likely to be similar for other sodium-coupled transporters that share the LeuT fold, and that a comparable principle seems to be found in other families of structurally disparate transporters, such as those adopting the GltPh fold.
Permeation pathways and gating mechanisms
In transporters with the GltPh fold (GltPh) and the LeuT fold (LeuT, vSGLT and Mhp1), the primary substrate-and ion-binding sites are flanked by two gates, one controlling access to the outside of the cell, the other controlling access to the inside. Only one of these gates can open at a time, allowing substrates and ions to reach the primary binding sites without opening up a continuous transmembrane pore. Understanding how secondary transporters work is fundamentally a question of how the gates work: what principles govern the coordinated, alternate opening and closing of the extracellular and intracellular gates when substrates bind on the outside and unbind on the inside. To answer this question, we must consider the conformational changes that occur during transport and the likely pathways that substrates and ions take when they bind to, and unbind from, their primary sites.
In the small group of sodium-coupled transporter structures, for a given transporter trapped in a specific state, the gates that control access to and from the primary binding site are often asymmetric, with the extracellular gate being less substantial or 'thinner' than the cytoplasmic gate, or vice versa (Fig. 4a) . This is observed for transporters with the GltPh fold as well as those with the LeuT fold. For example, in the outward-facing occluded leucine-bound LeuT complex, only a few residues directly block access from the primary binding site (Tyr 108 and Phe 253), forming a 'thin' gate at the base of a solvent-filled cavity to the outside. By contrast, the cytoplasmic 'thick' gate is made up of about 20 Å of packed protein, including TM1a, TM3, TM6b, TM8 and TM10, along with the N terminus and IL1 (Fig. 5a, c, e) . Similarly, in the substrate-bound state of GltPh, the extracellular gate is made up of just a few residues at the tip of HP2, whereas the cytoplasmic gate is composed of a roughly 15-Å slab of helices and side chains (HP1, TM7a and TM8).
The substrate-and ion-bound inward-facing occluded state of vSGLT presents a converse situation in which a thick extracellular gate is formed by TM1b, TM3, TM6a, TM10 and EL4 (numbering as LeuT) and a thin cytoplasmic gate is composed of Tyr 262, Tyr 263 and Trp 264 (Fig. 5b, d, f) . Thus, the thin gates are typically defined by the side-chain atoms of a few residues, whereas the thick gates are formed by transmembrane helices packed close together, in combination with extracellular and intracellular loops such as N termini, IL1 or EL4. A prominent observation from the structures of outward-facing LeuT and Mhp1, and inward-facing vSGLT, is that the thick gate of each transporter is related to the extracellular or intracellular pathway by the internal two-fold symmetry. In any one state, the structural components of the solvent-filled pathway are reciprocal (with respect to the axis of the two-fold symmetry) to those of the thick gates.
Insight into how the thin gate opens and closes is provided by the structures of LeuT states involves larger-scale conformational changes spread throughout the transporter. These conformational changes can be conceptualized by applying the two-fold axis of internal pseudosymmetry to the key transmembrane helices TM1 and TM6, which deviate from this symmetry 25, 60 . Rotation of TM1 and TM6 of LeuT about the internal symmetry axis generates an inward-facing model in which the extracellular gate is closed and the intracellular gate is open 60 . Based on this model, it was suggested that the bundle of TM1, TM2, TM6 and TM7 moves as a rigid body in a rocker-switch-like mechanism to alternately open and close the extracellular and intracellular gates 60 . However, this simplification is not consistent with the structural comparisons of the LeuT-Leu and LeuT-Trp complexes or of the Mhp1-apo and substrate-bound states, which indicate that, for example, TM1 is not a rigid body and that there is some degree of independent movement within the helix bundle. Further experimental and computational studies are required to understand the movements that describe this conformational change.
Nevertheless, comparison of the LeuT-Leu (outward-facing, T M S out ) and vSGLT-Gal (inward-facing, T M S in ) structures suggests that the differences between these states can be described by a reorientation of TM1 and TM6 (TM2 and TM7 in vSGLT), together with movement and bending of TM2 and TM7 (TM3 and TM8 in vSGLT). In the outward-facing state, near the extracellular opening in LeuT, TM1 is about 17 Å and 18 Å away from TM3 and TM10, respectively (Fig. 5a , c) compared with just 7 Å and 5 Å for the equivalent elements in vSGLT (Fig. 5b, d) . Similarly, the intracellular cavity is open in vSGLT about 16 Å, measured between TM9 and TM7 (Fig. 5b, f) , whereas the same elements in LeuT (TM6 and TM8), with the thick intracellular gate closed, are about 9 Å apart (Fig. 5a, e) . The similar magnitude to which the extracellular cavity of LeuT collapses to form the thick gate seen in vSGLT, and to which the thick intracellular gate of LeuT opens to form the cavity in vSGLT, supports the idea that the relationship between the cavities and the thick gates is reciprocally related by the two-fold internal symmetry of the transporter, and that structures of LeuT and vSGLT largely represent distinct occluded-state ternary intermediates that interconvert during transport. The reorientation of TM1, TM2, TM6 and TM7 (LeuT numbering) between an occluded LeuT-like conformation (T M S out ) and an occluded vSGLT-like conformation (T M S in ) is therefore likely to approximate the conformational transition that reorients the thin gates of a transporter to the opposite side of the membrane. Additionally, the flexing of TM3 and TM8 may also contribute to the opening and closing of the gates, with these transmembrane helices bending at conserved glycine residues near their midsections, and with IL1, EL4 and the N terminus functioning as flexible flaps, helping to seal the gates in the closed state.
Taken together, the crystal structures of the LeuT fold, namely Mhp1, LeuT and vSGLT, identify two major classes of transition that occur during transport. First, substrate binding and unbinding closes and opens, respectively, the thin gates to occlude or expose the substrate in the primary binding site. Second, the opening and closing of the thick gates switches the transporter between outward-facing and inwardfacing states. The opening and closing of the thin gates stem from local conformational changes, some of which involve helix rotations centred on axes that pass through the regions of helical discontinuity. By contrast, the thick-gate transition reorients the occluded substratetransporter complex by rotating the entire membrane-spanning bundle of helices about a central axis approximately perpendicular to the axis of internal two-fold symmetry (Fig. 6a, b) .
How do we know that comparing different transporters in different conformations reliably predicts common mechanistic principles? We don't, but the fact that transporters with the LeuT fold share several common elements of structure and symmetry suggests that basic mechanistic principles are also likely to be shared. However, specific details, related to substrate and transporter interactions and regulation, are likely to differ.
What prevents both gates from opening simultaneously? We suggest that the discontinuous helical regions of TM1 and TM6 provide a hinge around which a small degree of conformational change can occur. This can be seen in the movements that accompany the binding of the competitive inhibitor tryptophan to LeuT, in which the thin extracellular gate opens by outward movements of TM1b and TM6a. However, TM1 and TM6 are adjacent to TM2 and TM7, and together they form a four-helix bundle. Larger-scale movement of TM1b and TM6a is therefore constrained by TM2 and TM7, perhaps because the latter are continuous α-helices that lack the non-helical, hinge-like regions present in TM1 and TM6. So substantial outward (opening) movements of TM1b and TM6a, or of TM1a and TM6b, are limited by TM2 and TM7. As a result, both gates may be closed at the same time, but they are prevented from being simultaneously open by the conformational rigidity enforced by TM2 and TM7.
Future prospects
Recent crystallographic studies of sodium-coupled secondary transporters have greatly advanced our understanding of the structural principles that underlie transporter function. The consistency of these models with the earlier functional studies has allowed us to associate specific conformations with different mechanistic states of the transport cycle. However, this mechanistic description is derived from a patchwork of different transporters fortuitously crystallized in different states. An accurate description of the precise conformational changes that a given transporter undergoes during transport must await further structural, biophysical and computational studies of individual secondary transporters. Additionally, various questions regarding the fundamental nature of the transport cycle remain outstanding. Although it is fairly easy to see how substrate binding leads to the closure of a thin gate, it is harder to deduce the chemical and structural principles that drive the isomerization of the transporter from an outward-facing to an inward-facing state (in other words, open a thick gate). Unlike mechanical models of gating in primary transporters and ion channels, in secondary transporters there is no apparent source of mechanical force to open the thick gate. What structural changes occur in response to the binding of ions? What is the sequence of events that leads to the release of substrate on the cytoplasmic side? How do ions, such as potassium, promote the isomerization of glutamate and serotonin transporters from inward-facing to outward-facing states? Finally, in order to fully understand and appreciate the biological and pharmacological properties unique to human secondary transporters, we will need to solve the crystal structures of eukaryotic homologues. There is clearly much work still to do. 
